Med School: Separating Hype from Hope in Genome Science

Genomic discoveries were supposed to transform medicine and move us to a new vision of preventive health care. But 15 years after the Human Genome Project was complete, that still hasn’t happened. Meanwhile, direct-to-consumer genetics companies are bypassing health care providers to market ancestry, disease risk, diet, exercise and even dating and wine applications directly to the public. Robert Green, one of the world’s leaders in generating the evidence-base for genomic medicine, describes what's right and what’s wrong with the genomic revolution, and how we can realize the promise of precision medicine for all.
(Underwritten by America's Biopharmaceutical Companies)

Speakers: Robert C. Green
Festival: Spotlight Health 2018

Watch and Listen: Health

The US and many other countries have been locked in intense debate about the ethics of using embryonic stem cells for... See more
George Washington School of Public Health dean Ruth Katz talks with preventive medicine guru Dean Ornish, MD, and... See more
Workforces are aging in the industrialized World. And as life spans rise, older people require a large - some say... See more
Many patients have said, "Having a heart attack was the best thing that ever happened to me," or "Being diagnosed with... See more
Nutrition guru Dr. David Heber has become expert in a new area of nutrition, what he refers to as "personalized health... See more

Pages